Gilead Publishes 2025 Responsible Business and Impact Report, Highlighting Momentum Toward 2030 Ambitions

FOSTER CITY, Calif., April 21, 2026 - Gilead Sciences, Inc. today published its 2025 Responsible Business and Impact Report, outlining progress toward our 2030 ambitions and the priorities guiding our next phase of work: advancing breakthrough innovation, accelerating access at scale, investing in people and communities, and embedding sustainability across operations.

Among the progress reflected in this report:

• Advancing next-generation innovation across virology, oncology and inflammation, supported by 50+ clinical-stage programs-our most robust pipeline in company history.
• Designing access into the lifecycle of innovation, including steps to accelerate global access for our twice-yearly injectable HIV prevention medicine, with voluntary licensing covering 120 low- and lower-middle-income countries and partnerships intended to help bridge near-term access gaps.
• Strengthening health systems in the U.S. and globally through initiatives such as FOCUS, supporting routine screening and linkage to care for HIV, hepatitis B and hepatitis C, with partners performing more than 24.7 million screening tests in underserved communities.
• Investing in the communities where our employees live and work, through the Gilead Foundation and corporate giving programs, with $260M+ awarded in 2025 to help address social determinants of health, including STEM education, healthcare workforce pathways, food security and community resilience.
• Advancing sustainability outcomes aligned with measurable, globally recognized benchmarks, including achieving 100% renewable electricity in our operations and verified zero-waste-to-landfill performance at our Foster City headquarters.
• Continuing long-term investment in U.S. innovation and manufacturing capabilities, including groundbreaking for a new research and manufacturing development center at our Foster City headquarters as part of a multi-year U.S. investment commitment through 2030.

Gilead's 2025 Responsible Business and Impact Report is available here, accompanied by a Reporting Appendix with additional performance data and reporting standards alignment.

For more information about Gilead, please visit the company's website at www.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).